Quarraisha Abdool Karim | Academic Influence

Quarraisha Abdool Karim's AcademicInfluence.com Rankings

Quarraisha Abdool Karim

Philosophy

#4904

World Rank

#7578

Historical Rank

Logic

#2327

World Rank

#3300

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Quarraisha Abdool Karim's Degrees

PhD Epidemiology Columbia University

Why Is Quarraisha Abdool Karim Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Quarraisha Abdool Karim is an infectious diseases epidemiologist and co-founder and Associate Scientific Director of CAPRISA. She is a Professor in Clinical Epidemiology, Columbia University, New York and Pro-Vice Chancellor for African Health, University of KwaZulu-Natal, South Africa.

(See a Problem?)

Quarraisha Abdool Karim's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women (2010) (2178)
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results (2020) (2026)
Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic (2021) (757)
Timing of initiation of antiretroviral drugs during tuberculosis therapy. (2010) (728)
HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities (2016) (621)
HIV/AIDS epidemiology, pathogenesis, prevention, and treatment (2006) (614)
HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response (2009) (561)
Integration of antiretroviral therapy with tuberculosis treatment. (2011) (518)
Adolescent girls and young women: key populations for HIV epidemic control (2015) (399)
Achieving the health Millennium Development Goals for South Africa: challenges and priorities (2009) (360)
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women: Supporting Online Material (2010) (359)
Genital inflammation and the risk of HIV acquisition in women. (2015) (313)
Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women (2017) (307)
Hormonal Contraception and the Risk of HIV Acquisition: An Individual Participant Data Meta-analysis (2015) (307)
Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape (2012) (296)
Reducing the risk of HIV infection among South African sex workers: socioeconomic and gender barriers. (1995) (235)
Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study. (2017) (227)
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women (2011) (221)
Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa (2007) (215)
Establishing a Cohort at High Risk of HIV Infection in South Africa: Challenges and Experiences of the CAPRISA 002 Acute Infection Study (2008) (214)
Association of Surgery With Improved Survival in Stage IV Breast Cancer Patients (2008) (210)
Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression (2010) (209)
Why are 4 million newborn babies dying each year? (2004) (196)
Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes (2010) (190)
Informed consent for HIV testing in a South African hospital: is it truly informed and truly voluntary? (1998) (170)
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up (2012) (158)
Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study (2014) (151)
Grey matter: ageing in developing countries (2012) (149)
Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gel. (2012) (146)
HIV/AIDS in South Africa: Focal groups for understanding the HIV epidemic (2010) (146)
Seroprevalence of HIV infection in rural South Africa (1992) (144)
Preventing HIV infection in women: a global health imperative. (2010) (140)
Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa. (2011) (131)
FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. (2010) (124)
Public health: India's diabetes time bomb (2012) (121)
A model designed to enhance informed consent: experiences from the HIV prevention trials network. (2005) (115)
Reasons for lack of condom use among high school students. (1992) (112)
Global epidemiology of HIV-AIDS. (2007) (106)
Antiretroviral prophylaxis: a defining moment in HIV control (2011) (101)
The changing epidemiology of HIV in 2013 (2013) (98)
Ratio of Monocytes to Lymphocytes in Peripheral Blood Identifies Adults at Risk of Incident Tuberculosis Among HIV-Infected Adults Initiating Antiretroviral Therapy (2013) (98)
Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women (2018) (90)
Global Strategies for the Prevention of HIV Transmission from Mothers to Infants (2000) (83)
Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection. (2015) (83)
The numbers game (2012) (83)
HIV/AIDS in South Africa: Heterosexual transmission of HIV – the importance of a gendered perspective in HIV prevention (2005) (83)
Prevention of HIV in Adolescent Girls and Young Women: Key to an AIDS-Free Generation (2017) (82)
A Pilot Study of Once-Daily Antiretroviral Therapy Integrated With Tuberculosis Directly Observed Therapy in a Resource-Limited Setting (2004) (81)
Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women. (2012) (79)
Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization (2016) (78)
Relationship between levels of inflammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection. (2008) (78)
Teenagers seeking condoms at family planning services. Part I. A user's perspective. (1992) (77)
Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes (2018) (76)
Medical tourism booms in India, but at what cost? (2010) (72)
India faces growing breast cancer epidemic (2012) (72)
Family Planning and the Millennium Development Goals (2010) (71)
Genital Tenofovir Concentrations Correlate With Protection Against HIV Infection in the CAPRISA 004 Trial: Importance of Adherence for Microbicide Effectiveness (2015) (67)
HIV Incidence in Young Girls in KwaZulu-Natal, South Africa-Public Health Imperative for Their Inclusion in HIV Biomedical Intervention Trials (2012) (67)
Changes in Natural Killer Cell Activation and Function during Primary HIV-1 Infection (2013) (66)
Epidemiological Impact of Tenofovir Gel on the HIV Epidemic in South Africa (2011) (66)
Ability To Develop Broadly Neutralizing HIV-1 Antibodies Is Not Restricted by the Germline Ig Gene Repertoire (2015) (66)
Prevalence of HIV, HSV-2 and pregnancy among high school students in rural KwaZulu-Natal, South Africa: a bio-behavioural cross-sectional survey (2014) (63)
Phase 1 trial of nonoxynol-9 film among sex workers in South Africa. (1999) (63)
Integrating Gender into HIV/AIDS Programmes (2003) (63)
A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: Opportunities to improve healthcare quality (2008) (63)
Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome (2012) (62)
Omicron sub-lineages BA.4/BA.5 escape BA.1 infection elicited neutralizing immunity (2022) (61)
The influence of AIDS stigma and discrimination and social cohesion on HIV testing and willingness to disclose HIV in rural KwaZulu-Natal, South Africa (2008) (60)
Interventions to modify sexual risk behaviours for preventing HIV in homeless youth. (2011) (59)
The evolving HIV epidemic in South Africa (2002) (57)
Community-based HIV prevalence in KwaZulu-Natal, South Africa: results of a cross-sectional household survey. (2018) (57)
Women and AIDS: The Imperative for a Gendered Prognosis and Prevention Policy (1998) (55)
Enrolling Adolescents in Research on HIV and Other Sensitive Issues: Lessons from South Africa (2006) (55)
Experts concerned about vaccination backlash (2010) (54)
The acceptability of the female condom: Perspectives of family planning providers in New York City, South Africa, and Nigeria (2001) (53)
HIV prevalence among high school learners - opportunities for schools-based HIV testing programmes and sexual reproductive health services (2012) (52)
HIV-Associated Tuberculosis (2010) (51)
Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care (2004) (50)
India's unregulated surrogacy industry (2012) (50)
Trends in HIV Prevalence in Pregnant Women in Rural South Africa (2015) (50)
Omicron infection enhances Delta antibody immunity in vaccinated persons (2022) (49)
Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection (2015) (49)
Introducing the female condom through the public health sector: Experiences from South Africa (2000) (47)
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection (2022) (46)
Disclosure of Microbicide Gel Use to Sexual Partners: Influence on Adherence in the CAPRISA 004 Trial (2014) (45)
Patients' readiness to start highly active antiretroviral treatment for HIV (2005) (45)
Progesterone Receptor Isoform-Specific Promoter Methylation: Association of PRA Promoter Methylation with Worse Outcome in Breast Cancer Patients (2011) (44)
Strengthening HIV services for pregnant women: an opportunity to reduce maternal mortality rates in Southern Africa/sub‐Saharan Africa (2011) (43)
Screening for ‘window‐period’ acute HIV infection among pregnant women in rural South Africa (2010) (43)
Indonesia's breastfeeding challenge is echoed the world over. (2014) (41)
Sexual behaviour and knowledge of AIDS among urban black mothers. Implications for AIDS intervention programmes. (1991) (41)
Acceptability of HIV self-testing among men and women in KwaZulu-Natal, South Africa (2018) (41)
Uptake of provider-initiated HIV testing and counseling among women attending an urban sexually transmitted disease clinic in South Africa – missed opportunities for early diagnosis of HIV infection (2010) (41)
Implementation of Adolescent-Friendly Voluntary Medical Male Circumcision Using a School Based Recruitment Program in Rural KwaZulu-Natal, South Africa (2014) (40)
HIV/AIDS in South Africa: HIV infection in South Africa: the evolving epidemic (2010) (40)
Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries. (2004) (39)
High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South Africa (2016) (39)
Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa (2015) (39)
COVID-19 affects HIV and tuberculosis care (2020) (39)
Slow progress in ending female genital mutilation. (2014) (38)
Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive. (2015) (37)
Health care for urban poor falls through the gap (2011) (36)
Mechanisms of sexually transmitted infection‐induced inflammation in women: implications for HIV risk (2019) (36)
Cervicovaginal Inflammation Facilitates Acquisition of Less Infectious HIV Variants (2017) (35)
High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations. (2007) (35)
Contraceptive Choices, Pregnancy Rates, and Outcomes in a Microbicide Trial (2011) (35)
The HIV Epidemic in Southern Africa – Is an AIDS-Free Generation Possible? (2014) (34)
Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial (2011) (34)
Factors Driving the HIV Epidemic in Southern Africa (2016) (34)
Development of Methods for Cross-Sectional HIV Incidence Estimation in a Large, Community Randomized Trial (2013) (32)
Vertical HIV transmission in South Africa: translating research into policy and practice (2002) (31)
Adolescents and HIV Clinical Trials: Ethics, Culture, and Context (2007) (31)
Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection (2022) (31)
Comparative analysis of the remineralization potential of CPP–ACP with Fluoride, Tri-Calcium Phosphate and Nano Hydroxyapatite using SEM/EDX – An in vitro study (2019) (30)
Ethical Challenges in International HIV Prevention Research (2004) (30)
Safety of Tenofovir Gel, a Vaginal Microbicide, in South African Women: Results of the Caprisa 004 Trial (2013) (29)
Oxford Textbook of Global Public Health (2015) (29)
HIV-prevention science at a crossroads: advances in reducing sexual risk (2009) (28)
Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction (2015) (28)
Integrating Gender into HIV / AIDS Programmes a review paper (2003) (28)
The need for multipurpose prevention technologies in sub‐Saharan Africa (2014) (28)
Impact of an Adherence Intervention on the Effectiveness of Tenofovir Gel in the CAPRISA 004 Trial (2014) (27)
Variants in CXADR and F2RL1 are associated with blood pressure and obesity in African-Americans in regions identified through admixture mapping (2012) (27)
Disclosure of HIV status: experiences of patients enrolled in an integrated TB and HAART pilot programme in South Africa (2009) (27)
HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition (2019) (27)
Metabolic Syndrome After HIV Acquisition in South African Women (2016) (26)
South Africa: host to a new and emerging HIV epidemic. (1999) (26)
Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis. (2015) (26)
Co-enrollment in multiple HIV prevention trials - experiences from the CAPRISA 004 Tenofovir gel trial. (2011) (26)
HIV infection in high school students in rural South Africa: role of transmissions among students. (2014) (25)
Opportunities for treating sexually transmitted infections and reducing HIV risk in rural South Africa. (2007) (25)
Acceptability of Early Antiretroviral Therapy Among South African Women (2018) (25)
Adherence in the CAPRISA 004 Tenofovir Gel Microbicide Trial (2014) (25)
The parlous state of palliative care in the developing world (2010) (25)
Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection (2018) (24)
Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review (2020) (24)
Interventions with youth in high-prevalence areas (2009) (24)
More midwives needed to improve maternal and newborn survival. (2013) (24)
Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype (2015) (23)
Trends in HIV Prevention, Treatment, and Incidence in a Hyperendemic Area of KwaZulu-Natal, South Africa (2019) (23)
Understanding women and men’s acceptability of current and new HIV prevention technologies in KwaZulu-Natal, South Africa (2018) (23)
HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth (2018) (22)
Ethical challenges in global health-related stigma research (2019) (22)
South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication (2015) (22)
Gender-sensitive reporting in medical research (2012) (22)
Topical Microbicides—What's New? (2013) (21)
HIV-Positive Status Disclosure in Patients in Care in Rural South Africa: Implications for Scaling Up Treatment and Prevention Interventions (2015) (21)
Inclusion of adolescent girls in HIV prevention research – an imperative for an AIDS-free generation (2014) (21)
HIV/AIDS in South Africa: The future of the HIV epidemic in South Africa (2010) (20)
A review of progress on HIV, AIDS and Tuberculosis. (2010) (20)
HIV self-testing as part of a differentiated HIV testing approach: exploring urban and rural adult experiences from KwaZulu-Natal, South Africa using a cross-over study design (2019) (19)
Genital—Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women (2017) (19)
Initiating antiretrovirals during tuberculosis treatment: a drug safety review (2011) (19)
Trends in HIV/AIDS infection: Beyond current statistics (2000) (19)
The dual burden of gender-based violence and HIV in adolescent girls and young women in South Africa. (2016) (19)
Residual T cell activation and skewed CD8+ T cell memory differentiation despite antiretroviral therapy-induced HIV suppression. (2018) (19)
Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial (2014) (18)
South Africa: host to a new and emerging HIV epidemic (1999) (18)
Meeting the sexual and reproductive health needs of high-school students in South Africa: experiences from rural KwaZulu-Natal. (2014) (18)
Empowering women in human immunodeficiency virus prevention. (2012) (18)
Knowledge and acceptability of HAART among TB patients in Durban, South Africa (2005) (18)
AIDS research must link to local policy (2010) (17)
Secrecy, empowerment and protection: positioning PrEP in KwaZulu-Natal, South Africa (2017) (17)
Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Randomized-Controlled Trial (2013) (17)
Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial (2020) (17)
Me, myself, and I Guy Claxton The Wayward Mind: An Intim (2005) (17)
Women Try to Protect Themselves From HIV/AIDS in KwaZulu-Natal, South Africa (2000) (17)
Genital—Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women (2017) (17)
Limited HIV-1 Superinfection in Seroconverters from the CAPRISA 004 Microbicide Trial (2013) (17)
Vaccine trial's ethics criticized (2011) (17)
Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel (2015) (16)
Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women (2016) (16)
Asking the right questions: developing evidence-based strategies for treating HIV in women and children (2011) (16)
Preparation for a pandemic: influenza A H1N1 (2009) (16)
Antiretroviral prophylaxis for HIV prevention reaches a key milestone (2012) (16)
CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck. (2012) (16)
Preservation HIV-1–Specific IFN&ggr;+ CD4+ T-Cell Responses in Breakthrough Infections After Exposure to Tenofovir Gel in the CAPRISA 004 Microbicide Trial (2012) (16)
High Rates of Tuberculosis in Patients Accessing HAART in Rural South Africa (2014) (16)
Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis (2021) (16)
Patterns of Infection: Using Age Prevalence and Incidence Data to Understand the Epidemic of HIV in South Africa (2000) (16)
Sensitive tenofovir resistance screening of HIV-1 from the genital and blood compartments of women with breakthrough infections in the CAPRISA 004 tenofovir gel trial. (2014) (16)
Integrin alpha(4)beta(7) expression on peripheral blood CD4(+) T cells predicts HIV acquisition and disease progression outcomes (15)
Government responses to HIV/AIDS in Africa: what have we learnt? (1997) (15)
Experience in international clinical research: the HIV Prevention Trials Network. (2011) (15)
Asymptomatic Bacterial Vaginosis in Pregnancy and Missed Opportunities for Treatment: A Cross-Sectional Observational Study (2019) (15)
Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression (2017) (15)
The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis. (2010) (15)
Natural killer cell function in women at high risk for HIV acquisition: insights from a microbicide trial (2012) (15)
Microbicides for the prevention of sexually transmitted HIV infection (2013) (14)
Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African women (2015) (14)
Antiretroviral therapy: challenges and options in South Africa (2003) (14)
Inclusion of Adolescent Women in Microbicide Trials: A Public Health Imperative! (2010) (14)
Understanding and responding to HIV risk in youngSouth African women: Clinical perspectives. (2015) (14)
Repeat HIV testing practices in the era of HIV self-testing among adults in KwaZulu-Natal, South Africa (2019) (14)
Ending AIDS as a public health threat by 2030: Time to reset targets for 2025 (2021) (14)
COVID-19 affects HIV and tuberculosis care. (2020) (13)
Teenagers seeking condoms at family planning services. Part II. A provider's perspective. (1992) (13)
Plasma concentration of injectable contraceptive correlates with reduced cervicovaginal growth factor expression in South African women (2020) (13)
Effect of Antiretroviral Therapy on the Memory and Activation Profiles of B Cells in HIV-Infected African Women (2017) (13)
Scaling up HIV testing in resource-constrained settings: Debates on the role of VCT and Routine ‘Opt-in or Opt-out’ HIV Testing (2005) (13)
Time for gender mainstreaming in editorial policies (2011) (13)
Utilizing nucleic acid amplification to identify acute HIV infection. (2007) (12)
High AIDS-related mortality among young women in rural KwaZulu-Natal. (2007) (12)
Variants for HDL-C, LDL-C, and Triglycerides Identified from Admixture Mapping and Fine-Mapping Analysis in African American Families (2015) (12)
Monitoring Microbicide Gel Use with Real-Time Notification of the Container’s Opening Events: Results of the CAPRISA Wisebag Study (2014) (12)
HIV prevalence among high school learners - opportunities for school-based HIV testing programmes and sexual reproductive health services. (2012) (11)
Ethics guidance for HIV prevention trials (2003) (11)
COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa (2022) (11)
No Evidence for Selection of HIV-1 with Enhanced Gag-Protease or Nef Function among Breakthrough Infections in the CAPRISA 004 Tenofovir Microbicide Trial (2013) (11)
Changes in HIV seroprevalence in a rural black community in KwaZulu. (1992) (11)
Social Context of Adherence in an Open-Label 1 % Tenofovir Gel Trial: Gender Dynamics and Disclosure in KwaZulu-Natal, South Africa (2016) (11)
Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial (2014) (11)
Assessing Adherence in the CAPRISA 004 Tenofovir Gel HIV Prevention Trial: Results of a Nested Case–Control Study (2014) (11)
Unsustainability of a measles immunisation campaign--rise in measles incidence within 2 years of the campaign. (1993) (10)
How important is neutrality to humanitarian aid agencies? (2007) (10)
Integrated provision of topical pre‐exposure prophylaxis in routine family planning services in South Africa: a non‐inferiority randomized controlled trial (2019) (10)
Impact of a measles immunisation campaign on measles admissions to a Natal hospital. (1991) (10)
Antibodies for HIV prevention in young women (2015) (10)
Home-Based Care (2002) (10)
HIV treatment in South Africa: overcoming impediments to get started. (2004) (9)
CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women (2022) (9)
Current status of the HIV epidemic & challenges in prevention (2017) (9)
TB treatment outcomes following directly-observed treatment at an urban outpatient specialist TB facility in South Africa (2006) (9)
Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies (2014) (9)
Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses (2017) (9)
HIV/AIDS in South Africa: Overview of the book (2010) (9)
Implementing microbicides in low-income countries. (2012) (9)
The Preventive Misconception: Experiences from CAPRISA 004 (2014) (9)
Barriers To Dental Care for Children with Autism Spectrum Disorder- A Pilot Study (2016) (8)
Measuring Adherence by Visual Inspection of Returned Empty Gel Applicators in the CAPRISA 004 Microbicide Trial (2014) (8)
Bogaletch Gebre: ending female genital mutilation in Ethiopia (2007) (8)
Kidney function in tenofovir disoproxil fumarate-based oral pre-exposure prophylaxis users: a systematic review and meta-analysis of published literature and a multi-country meta-analysis of individual participant data (2022) (8)
Development of a prognostic tool exploring female adolescent risk for HIV prevention and PrEP in rural South Africa, a generalised epidemic setting (2019) (8)
Microbicide Research and Development—Where To? (2001) (8)
Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women (2018) (7)
Exploring factors that influence the integration of HIVST with HCT using a qualitative comparative cross-over design in KwaZulu-Natal, South Africa (2019) (7)
The Global HIV Epidemic: Current Status and Challenges (2013) (7)
Global fund switches to artemisinin. (2004) (7)
Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake (2017) (7)
Identification of adolescent girls and young women for targeted HIV prevention: a new risk scoring tool in KwaZulu Natal, South Africa (2020) (7)
Prevention of HIV by male circumcision (2007) (7)
Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives (2020) (7)
Relationship between Levels of Inflammatory Cytokines in the Genital Tract and CD 4 Cell Counts in Women with Acute HIV-1 Infection (2008) (7)
In vivo Evaluation of Two Thiazolidin-4-one Derivatives in High Sucrose Diet Fed Pre-diabetic Mice and Their Modulatory Effect on AMPK, Akt and p38 MAP Kinase in L6 Cells (2016) (7)
Prevention of HIV by male circumcision. (2007) (6)
Breaking the silence, one year later: reflections on the Durban Conference. (2001) (6)
Children in conflict (2010) (6)
Safe blood supplies (2010) (6)
Exploratory analysis of the ecological variables associated with sexual health profiles in high-risk, sexually-active female learners in rural KwaZulu-Natal (2018) (6)
Neither Microbial Translocation Nor TLR Responsiveness Are Likely Explanations for Preexisting Immune Activation in Women Who Subsequently Acquired HIV in CAPRISA 004 (2013) (6)
The Impact of Conditional Cash Transfers in Reducing HIV in Adolescent Girls and Boys (RHIVA): The CAPRISA 007 Matched Pair, Cluster Randomised Controlled Trial (2017) (6)
H1N1 vaccination struggles against resistance and supply (2010) (6)
Diverse approaches useful for microbicide trials (2007) (6)
Arabic roots of modern medicine (2011) (6)
Sustainability of task-shifting for antiretroviral treatment (2012) (6)
Home DNA test kits cause controversy (2008) (6)
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide (2017) (5)
Celebrating 65 years of the NSHD cohort (2011) (5)
Tax cuts for organs? (2009) (5)
Acceptability of neonatal circumcision by pregnant women in KwaZulu-Natal, South Africa (2015) (5)
HIV prevention and treatment research in sub-Saharan Africa: where are the adolescents? (2006) (5)
Under-reporting in hepatitis B notifications. (1991) (5)
H1N1 vaccine access and excess (2010) (5)
Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women (2021) (5)
HIV recency testing: should results be disclosed to individuals tested? (2020) (5)
Swine-origin influenza A H1N1 update. (2009) (5)
The dual burden of gender-based violence and HIV in adolescent girls and young women in South Africa : guest editorial (2016) (5)
HIV treatment in South Africa: overcoming impediments to get started (2004) (5)
The Global HIV Epidemic: Current Status and Challenges (2013) (5)
Martin McKee: champion of public health in Europe (2013) (5)
The Impact of Semen Exposure on the Immune and Microbial Environments of the Female Genital Tract (2020) (5)
Challenges with participant reimbursement: experiences from a post-trial access study (2015) (5)
Under-reporting in hepatitis B notifications. (1991) (5)
Direct questioning of genital symptoms: increasing opportunities for identifying and treating sexually transmitted infections in primary health-care settings. (2006) (5)
Citizen scientists' climate-impact survey wraps up (2011) (5)
Sulafa Ali: a pioneer of paediatric cardiology in Sudan (2014) (5)
Tony McMichael: a visionary of the environment–health interface (2006) (5)
Kevin De Cock: guiding HIV/AIDS policy at WHO (2008) (5)
Comprar HIV/AIDS in South Africa | S. S. Abdool Karim | 9780521147934 | Cambridge University Press (2010) (5)
Experiences in the implementation of provider-initiated counselling and testing and linkage to HIV services at urban public sector health facilities in KwaZulu-Natal (2015) (4)
Nora Volkow—challenging the myths about drug addiction (2011) (4)
Estimating heritability using family and unrelated individuals data (2011) (4)
Meena Saraswathi Seshu: tackling HIV for India's sex workers (2010) (4)
Rani and Abhay Bang—pioneers of health care in rural India (2011) (4)
Qatar sets its sights on global scientific domination (2011) (4)
Melanoma Decision Support System for Dermatologist (2012) (4)
Kinari Webb: saving lives and saving rainforests (2009) (4)
Will Britain be sidelined by the rise of Asian science? (2007) (4)
Build on HIV investments for future pandemic preparedness (2021) (4)
Expanding HIV surveillance to include TB patients in resource-limited settings with a generalized epidemic. (2009) (4)
Putting women in the centre of the global HIV response is key to achieving epidemic control! (2020) (4)
Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
tuberculosis amongst patients initiating antiretroviral therapy (2013) (4)
Increasing burden of pulmonary tuberculosis in young women. (2006) (4)
HIV—No time for complacency (2018) (3)
Honing in on enteric fever (2014) (3)
Science and Islam Ehsan Masood Science and Islam: A History (2009) (3)
More Creative Thinking Needed On Drug R&D (2005) (3)
Information systems in support of public health in high-income countries. (2015) (3)
Protecting health-care workers in the firing line (2013) (3)
Transient association between semen exposure and biomarkers of genital inflammation in South African women at risk of HIV infection (2021) (3)
Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression (2022) (3)
Putting pain to bed Linda Stratmann Chloroform: the ques (2004) (3)
Importance of early identification of PrEP breakthrough infections in a generalized HIV epidemic: a case report from a PrEP demonstration project in South Africa (2020) (3)
Monogamy gene found in people (2008) (3)
Clinic-Based Evaluation of a Point-of-Care Creatinine Assay to Screen for Renal Impairment Among HIV-Positive Patients Receiving Tenofovir Disoproxil Fumarate (2017) (3)
How to keep science local (2008) (3)
Funding doubts for Roll Back Malaria initiative (2004) (3)
Plagiarism plagues India's genetically modified crops (2010) (3)
Who is sexually active? Using a multi-component sexual activity profile (MSAP) to explore, identify and describe sexually-active high-school students in rural KwaZulu-Natal, South Africa (2019) (3)
Never say die? Bryan Appleyard How to Live Forever or Die Trying: On the New Immortality (2007) (2)
Engaging young women in Africa for PrEP use and adherence. (2021) (2)
Films that deliver (2013) (2)
Women and AIDS: epidemiology and gender barriers to prevention in KwaZulu-Natal, South Africa. (2000) (2)
The Life Course of Black Women in South Africa in the 1990s: Generation, Age, and Period in the Decade of HIV and Political Liberation (2002) (2)
Quarraisha Abdool Karim: investigating HIV/AIDS in South Africa (2009) (2)
33 – Women and HIV/AIDS: A Global Perspective: Epidemiology, Risk Factors and Challenges (2000) (2)
Indian generics giants set sights on Japan (2011) (2)
Enhancing HIV Prevention with Injectable Preexposure Prophylaxis. (2021) (2)
Implants for HIV prevention in young women: Provider perceptions and lessons learned from contraceptive implant provision (2022) (2)
Challenges in HIV-prevention microbicide research. (2008) (2)
Genital and systemic immune effects of the injectable, contraceptive norethisterone enanthate (NET‐EN), in South African women (2021) (2)
Cash cure for the AIDS epidemic (2011) (2)
Efficacy and Safety of Tenofovir-Containing Antiretroviral Therapy in Women who Acquired HIV while Enrolled in Tenofovir Gel Prophylaxis Trials (2016) (2)
Kamiar and Arash Alaei: championing HIV/AIDS initiatives in Iran (2011) (2)
UK Government considers supervised injecting clinics (2008) (2)
Mental-health services for children patchy in the UK (2007) (2)
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention (2022) (2)
Production: Vaccines from the East (2014) (2)
Thought power (2006) (2)
Promoting HIV vaccine research and development in southern Africa. (1997) (2)
Anti-retrovirals for treatment and prevention--time for new paradigms in our response to the HIV/AIDS epidemic? (2013) (2)
Diverse approaches useful for microbicide trials. (2007) (2)
Hilda Tadria: proponent of gender equality and maternal health (2006) (2)
India to cut out animal dissection (2011) (2)
Immunological correlates of the HIV-1 replication-competent reservoir size. (2021) (2)
Appeal to global donors to save the Treatment Action Campaign (2014) (2)
Novartis challenges India's patent law (2012) (2)
Andy Haines: exploring the effects of global environmental change and energy use on health (2007) (2)
The antibiotic paradox (2002) (2)
HIV Epidemiology and Prevention (2011) (2)
Living with dignity Thomas Graboys Peter Zheutlin (2008) (2)
Meeting the sexual and reproductive needs of high-school students in South Africa : experiences from KwaZulu-Natal, SAMJ 104 (10) 2014 pp. 687-690 : erratum (2015) (2)
Talking Back to Science: Art, Science and the Personal, Bergit Arends, Verity Slater (Eds.). Wellcome Trust (2004), 56, £5.00, ISBN: 1-84129-052-1 (2004) (2)
‘You’ll always stay right’: understanding vaginal products and the motivations for use among adolescent and young women in rural KZN (2019) (2)
Quarraisha Abdool Karim: investigating HIV/AIDS in South Africa. Interview by Priva Shetty. (2009) (2)
Vaginal microbial shifts are unaffected by oral pre-exposure prophylaxis in South African women (2022) (2)
HIV epidemic types and customized prevention responses. (2008) (2)
Early evolution of human leucocyte antigen-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C-infected women (2017) (2)
Fred Binka: fighting malaria in Africa (2008) (1)
Safety of coitally administered tenofovir 1% gel, a vaginal microbicide, in chronic hepatitis B virus carriers: results from the CAPRISA 004 trial. (2013) (1)
Chilling side-effects (2009) (1)
antiretroviral treatment for HIV Patients' readiness to start highly active (2005) (1)
Endoxifen for breast cancer: Multiple-dose, dose-escalation study characterizing pharmacokinetics and safety in metastatic breast cancer patients. (2012) (1)
Dagfinn Høybråten—new Board Chair of GAVI Alliance (2011) (1)
Lumo's story (2007) (1)
Track C Epidemiology and Prevention Science (2012) (1)
Kenyan HIV stories (2010) (1)
Clinical Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Rapid Antigen Tests During the Omicron Wave in South Africa (2022) (1)
Exorcising the ghost in the machine Chris Nunn De La Met (2006) (1)
Fearless in the face of Nicaragua's abortion law (2015) (1)
Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome (2012) (1)
MSF workers attacked in Afghanistan (2004) (1)
West Nile virus causes poliomyelitis-like syndrome (2002) (1)
South Africa's Response to Preventing HIV/AIDS and Other STDs in Women: Introducing Female Controlled Methods in the Public Sector (1996) (1)
Colliding epidemics of communicable and non-communicable diseases during adolescence in South Africa (2016) (1)
Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women (2020) (1)
The verdant assassin Andrew A Meharg Venomous Earth: How (2005) (1)
Twalib Ngoma: creating cancer care in Tanzania (2008) (1)
Research organizations push back against clinical trials directive (2011) (1)
Closing the NIH Fogarty Center threatens US and global health (2017) (1)
Higher mucosal antibody concentrations in women with genital tract inflammation (2021) (1)
Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004) (2012) (1)
The CAPRISA Clinical Trials: HIV Treatment and Prevention (2017) (1)
Governmental Support of Research (2009) (1)
Health frontiers (2013) (1)
The use of simulation training module to train surgical residents in the focused assessment with sonography for trauma (FAST) (2019) (1)
Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization (2017) (1)
Living with hunger (2009) (1)
Novels act like social glue, say literary Darwinists (2009) (1)
31. HIV/AIDS, food insecurity, and undernourishment: amplifying cycles of risk in vulnerable populations (2015) (1)
Elodie Ghedin: intrepid gene hunter (2012) (1)
HIV—No time for complacency (2018) (1)
Prospective study of oral pre‐exposure prophylaxis initiation and adherence among young women in KwaZulu‐Natal, South Africa (2022) (1)
Erratum: Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel (Mucosal Immunology (2016) 9, (834)) doi:10.1038/mi.2016.21 (2016) (1)
Pantomath: College Inquiry Chatbot (2018) (1)
The HIV Pandemic: Local and Global Implications (2007) (1)
Preventing New HIV Infections in the Developing World (2009) (1)
H1N1 vaccine could staunch further financial loss (2009) (1)
Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial. (2023) (1)
Rolling Out of Tenofovir Gel in Family Planning Clinics: The CAPRISA 008 Implementation Trial (2017) (1)
Germline Ig Gene Repertoire HIV-1 Antibodies Is Not Restricted by the Ability To Develop Broadly Neutralizing (2015) (1)
Enhancing oral PrEP uptake among adolescent girls and young women in Africa (2022) (1)
Nahid Toubia (2007) (1)
HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa (2016) (1)
Mental health of and substance use by adolescents (2016) (1)
Battling the virus (2010) (1)
Marlene Kong: one of Australia's few Indigenous doctors (2009) (1)
Triple-negative breast cancers: Biomarkers and outcomes. (2010) (1)
Impact of COVID-19 public health responses on income, food security and health services among key and vulnerable women in South Africa (2022) (1)
Reducing Women's Risk: Men the Missing Link? (1998) (1)
Re: "Enhancement of HIV infection by cellulose sulfate," by Tao et al. (2009) (1)
Review: Remarkable Creatures by Sean B. Carroll (2009) (0)
HPTN at CROI 2018 Sunday (2018) (0)
Venomous Earth: How Arsenic Caused the World's Worst Mass Poisoning, Andrew A Meharg. Palgrave Macmillan (2005), Pp 208. £29·95., ISBN: 1-4039-4499-7 (2005) (0)
Epidemiological update on HIV and women (2008) (0)
Anne Johnson (2011) (0)
Adrienne Germain: helping to shape policy for women's health (2011) (0)
Breaking the silence (2008) (0)
Beate Kampmann: research advocate for children with tuberculosis (2012) (0)
Media WatchMe, myself, and IGuy Claxton, The Wayward Mind: An Intimate History of the Unconscious, Little, Brown (2005), £20, 401 pages, ISBN: 0 316 72451 3 (2005) (0)
TUPDC0103: Gonorrhea infections diagnosed among persons living with HIV: cross matching surveillance registries to identify potential opportunities for integrated partner services-New York City, Washington D.C., Miami/Dade County and Arizona (2012) (0)
No increased endometrial-cancer risk after breast cancer (2002) (0)
Tales from Tapologo (2009) (0)
In fl ammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection (2016) (0)
Gill Samuels (2007) (0)
Ashok Alexander: taking on the challenge of AIDS in India (2005) (0)
Exhibition Dr Johnson and friends (2003) (0)
Review: Coming of Age in Second Life by Tom Boellstorff (2008) (0)
Comment on: Enhancement of HIV Infection by Cellulose Sulfate, by Tao et al (2009) (0)
Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004) (2012) (0)
Abstract 5223: Pediatric cancer incidence among racial/ethnic groups living in rural/urban areas of the United States (2022) (0)
9.13 Acquired immunodeficiency syndrome (2009) (0)
Additional file 6: Figure S4. of Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African women (2016) (0)
A sense of the future (2011) (0)
Surgery and conflict (2014) (0)
Private support of public health (2021) (0)
Gory stories of symbiosis Eugene H Kaplan What's Eating You? People and Parasites (2010) (0)
Manisha Gupte—working to empower women in rural India (2010) (0)
Nicholas White—winner of 2010 Gairdner Global Health Award (2010) (0)
Cracking the code—the malaria genome revealed (2002) (0)
A cult collection (2004) (0)
Sarah Tabrizi: tracking Huntington's disease (2012) (0)
Gairdner Foundation names global health award winner (2011) (0)
Acute Pre-seroconversion HIV Infection at Baseline Prior to Starting Oral or Topical Pre-Exposure Prophylaxis: iPrEx and CAPRISA 004 (2010) (0)
What Does the Future Hold for CAPRISA (2017) (0)
Kiran's story (2010) (0)
Alternative views (2006) (0)
Continuing Medical Education (2021) (0)
Scanning the self (2013) (0)
South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication (2015) (0)
Special Collection: A pioneer in antiviral drug discovery and development: Commemorating John Martin-Review (2022) (0)
Lihadh Al-Gazali: a leading clinical geneticist in the Middle East (2006) (0)
Agnes Moses: preventing maternal transmission of HIV in Malawi (2010) (0)
COVID-19: The Challenge of Global Vaccine Inequity (2023) (0)
Questions of identity (2010) (0)
P06.13 Inflammatory cytokine biomarkers identify women with asymptomatic genital infections that increase the risk of hiv infection (2015) (0)
Too busy to have cancer? Marisa Acocella Marchetto Cancer Vixen (2007) (0)
Advancing HIV prevention using tenofovir-based pre-exposure prophylaxis (2022) (0)
The power of HIV/AIDS epidemiology. (2009) (0)
Tenofovir Gel to Prevent HSV-2 Infection. (2015) (0)
Are men heading towards extinction? Bryan Sykes Adam's Curse: a Future Without Men (2004) (0)
Exhibition: Cracking the Da Vinci code (2006) (0)
Identification of adolescent girls and young women for targeted HIV prevention: a new risk scoring tool in KwaZulu Natal, South Africa (2020) (0)
Beating hearts Max S Gerber My Heart vs the Real World: (2008) (0)
Plasma concentration of injectable contraceptive correlates with reduced cervicovaginal growth factor expression in South African women (2020) (0)
Audio Interview: Preparing for the Next Pandemic. (2023) (0)
Exploring discrepant knowledge of partner sexual behaviour to inform self-risk assessment in a high HIV burdened district in rural KwaZulu-Natal (2021) (0)
Genital immune cell activation and tenofovir gel efficacy: a case-control study. (2022) (0)
Omicron infection enhances Delta antibody immunity in vaccinated persons (2022) (0)
Abstract 4827: A novel FGFR2 haplotype is associated with increased risk of breast cancer in African American women (2010) (0)
Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression (2022) (0)
The whole story (2004) (0)
The final taboo John Temple Deadhouse: Life in a Coroner (2005) (0)
Fine-Mapping of SMAD6 Sequence Data Identifies Additional Putative Risk Loci for Langerhans Cell Histiocytosis (2022) (0)
David Eagleman (2011) (0)
Age-Restriction of a Validated Risk Scoring Tool Better Predicts HIV Acquisition in South African Women: CAPRISA 004 (2022) (0)
The great pinkwash (2012) (0)
National and international readiness for renewed pandemic (2009) (0)
Sex: just say no? Alesha E Doan Jean Calterone Williams (2008) (0)
Pramilla Senanayake (2008) (0)
Ties Boerma: improving health statistics (2007) (0)
Brian Greenwood: making milestones in malaria research (2008) (0)
Lindsey Davies (2010) (0)
Anand Grover: leading the defence of human rights (2011) (0)
Speaking out about sexual violence (2015) (0)
Review: Hysteria: The biography by Andrew Scull (2009) (0)
A snapshot of 21st-century science (2005) (0)
Molecular biologist Andrea Brand: encouraging women in science (2008) (0)
Bernard Pécoul: championing the cause of neglected diseases (2010) (0)
Bioterrorism assessments from the CDC (2004) (0)
Adeeba Kamarulzaman: fighting HIV/AIDS in Malaysia (2013) (0)
Douglas Young (2005) (0)
S17.2 Hpv infection, genital inflammation, and hiv risk in the caprisa 004 trial (2015) (0)
A life in the lyme light (2009) (0)
Phonetic rehabilitation by speech therapy following lingual frenectomy (2020) (0)
Community Case Studies in North America (2005) (0)
Additional file 4: Figure S3. of Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African women (2016) (0)
Mary Moran (2005) (0)
Life in the Balance: A Physician's Memoir of Life, Love, and Loss with Parkinson's Disease and Dementia, Thomas Graboys, Peter Zheutlin. Union Square Press (2008), Pp 224. US$19·95., ISBN: 1-4027-5341-1 (2008) (0)
HPTN at CROI 2018 (2018) (0)
Bindheshwar Pathak (2011) (0)
The smoking gun (2010) (0)
Iranian AIDS doctors continued work behind bars (2011) (0)
Predictive Biomarkers and Personalized Medicine Progesterone Receptor Isoform-Specific Promoter Methylation : Association of PRA Promoter Methylation with Worse Outcome in Breast Cancer Patients (2011) (0)
Acquired immunodeficiency syndrome (AIDS) (2021) (0)
Media medicine Martin King Katherine Watson (2005) (0)
Drugs, Gender-Based Violence, and Sex Work Intersect in the HIV/AIDS Epidemic in South Africa (2008) (0)
Representing Health: Discourses of Health and Illness in the Media, Martin King, Katherine Watson. Palgrave (2005), Pp 284. £18·99, ISBN: 0-333-99787-5 (2005) (0)
Review: Chasing Medical Miracles by Alex O'Meara (2009) (0)
Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel (2016) (0)
Elizabeth Pisani (2008) (0)
The HIV Pandemic: Local and Global Implications (2007) (0)
Commentary title: COVID-19 research, Africa, and global health (2021) (0)
Progesterone Receptor (PR) Promoter Methylation – Role as a Predictive and Prognostic Marker in Breast Cancer. (2009) (0)
Enhancing TBDiagnosis in HIV-Infected Patients and Knowledge of HIV Status in TB Patients and Prophylactic Use of Isoniazid (2010) (0)
Man on the moon (2009) (0)
Admixture mapping in African Americans identifies new risk loci for HCV-related cirrhosis. (2022) (0)
Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Trial (2013) (0)
Topical formulations antivirals for prevention of transmission of HSV-2 (2011) (0)
Attending with care Margaret E Mohrmann Attending Childr (2005) (0)
Body maps of HIV (2008) (0)
Case records of the Massachusetts General Hospital. Case 15-2011. A 19-year-old South African woman with headache, fatigue, and vaginal discharge. (2011) (0)
Ndola Prata: fighting for women's reproductive health (2012) (0)
Best Practice & Research Clinical Obstetrics and Gynaecology (2012) (0)
Go-ahead for ECDC (2004) (0)
Iconographies supplémentaires de l'article : The antibiotic paradox (2011) (0)
Getting personal Bergit Arends Verity Slater (2004) (0)
Making WHO recommendations more responsive (2014) (0)
Changing seasons herald a new phase in the H1N1 pandemic (2009) (0)
Review: Taking the Medicine by Druin Burch (2009) (0)
Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention (2022) (0)
HIV in the Developing World (2009) (0)
Melissa Leach (2008) (0)
The diseases you never knew you could catch (2009) (0)
Nizal Sarrafzadegan: leading cardiovascular research in Iran (2007) (0)
Author index to volume 198 (2001) (0)
Discover DNA (2008) (0)
Improving health outcomes of HIV infected pregnant women: experiences from rural KwaZulu-Natal Antenatal Primary Health Care Clinics (2012) (0)
Malnutrition snapshots (2010) (0)
Kidney Function in Oral Pre-Exposure Prophylaxis Users: A Systematic Literature Review and Individual Patient Data Meta-Analysis (2021) (0)
Is there a cure for AIDS? (1996) (0)
Acquired immunodefi ciency syndrome (2009) (0)
Herawati Sudoyo: champion of basic science in Indonesia (2012) (0)
Antoine's world (2009) (0)
Performance of Rapid Antigen Tests in Identifying Omicron Ba.4 and Ba.5 Infections in South Africa (2023) (0)
The Wayward Mind: An Intimate History of the Unconscious, Guy Claxton. Little, Brown (2005), £20, 401 pages, ISBN: 0 316 72451 3 (2005) (0)
HIV in Women. (2014) (0)
Mirror neurons not all they are cracked up to be (2009) (0)
Antiretrovirals for HIV Prevention: The CAPRISA 004 Tenofovir Gel Trial (2017) (0)
Functional analyses of Nef clones from treatment and placebo arms. (2013) (0)
Facing the fear of fear itself (2004) (0)
Virgin Olive Oils (2017) (0)
The tyranny of tradition (2011) (0)
Drama therapy (2014) (0)
Adolescent health. (2015) (0)
Early evolution of HLA-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C infected women. (2017) (0)
Leveraging the HIV response to strengthen pandemic preparedness (2023) (0)
Daniel De Backer: intensive work for intensive care. (2013) (0)
Carl Hart: advocate for rational drug policy (2014) (0)
Additional file 3: Figure S2. of Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African women (2016) (0)
Snapshots of HIV (2005) (0)
Studies Linked to the Evolving HIV Epidemic in South Africa: Informing the CAPRISA Scientific Agenda (2017) (0)
Members only for EU health care. (2004) (0)
FDA clears antibody test for West Nile virus (2003) (0)
CAPRISA: Establishing a Research Centre to Undertake HIV Clinical Trials (2017) (0)
Genetic Epidemiology of Hypertension in Populations: Applications of Modified Methods (2014) (0)
i-Kisaan (2021) (0)
Last ditch bid to save the orang-utan (2009) (0)

This paper list is powered by the following services:

Other Resources About Quarraisha Abdool Karim

en.wikipedia.org

What Schools Are Affiliated With Quarraisha Abdool Karim?

Quarraisha Abdool Karim is affiliated with the following schools:

Image Attributions

Image Source for Quarraisha Abdool Karim